Published August 7, 2010
| Version v1
Journal article
The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein
Creators
Contributors
Others:
- Service de génétique médicale ; Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital l'Archet
- Instabilité génétique : maladies rares et cancers (IGMRC) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)
- Université Montpellier 1 - UFR de Médecine (UM1 Médecine) ; Université Montpellier 1 (UM1)
- Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement (Inserm U781) ; Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Service de Biochimie ; Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice)
- Department of Clinical Genetics ; National University Hospital Rigshospitalet
- Service de neuropathologie ; Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
- Service de pédiatrie ; Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital l'Archet
- Service de neuropédiatrie ; CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin
- Service de neuropédiatrie ; Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
Description
Succinate-CoA ligase deficiency is responsible for encephalomyopathy with mitochondrial DNA depletion and mild methylmalonic aciduria. Mutations in SUCLA2, the gene encoding a β subunit of succinate-CoA ligase, have been reported in 17 patients until now. Mutations in SUCLG1, encoding the α subunit of the enzyme, have been described in two pedigrees only. We report two unrelated patients harboring three novel pathogenic mutations in SUCLG1. The first patient had a severe disease at birth. He was compound heterozygous for a missense mutation (p.Pro170Arg) and a c.97+3G>C mutation which leads to the complete skipping of exon 1 in a minigene expression system. The involvement of SUCLG1 was confirmed by western blot analysis, which showed absence of SUCLG1 protein in fibroblasts. The second patient has a milder phenotype, similar to that of patients with SUCLA2 mutations, and is still alive at 12 years of age. Western blot analysis showed some residual SUCLG1 protein in the patient¡¦s fibroblasts. Our results suggest that SUCLG1 mutations that lead to complete absence of SUCLG1 protein are responsible for a very severe disorder with antenatal manifestations, whereas a SUCLA2-like phenotype is found in patients with residual SUCLG1 protein. Furthermore, we show that in the absence of SUCLG1 protein, no SUCLA2 protein is found in fibroblasts by western blot analysis. This result is consistent with a degradation of SUCLA2 when its heterodimer partner, SUCLG1, is absent.
Abstract
International audienceAdditional details
Identifiers
- URL
- https://hal.archives-ouvertes.fr/hal-00557375
- URN
- urn:oai:HAL:hal-00557375v1
Origin repository
- Origin repository
- UNICA